Kerstin Dolph joined Charles River in 2001 in a Finance role for the Company’s Research Models and Services (RMS) business in Germany. She transitioned to the U.S. RMS business in 2009, and was promoted to Senior Finance Director of Global RMS in 2015. In 2017, Ms. Dolph was promoted to Corporate Vice President, North American RMS, where she was responsible for leading the Company’s North American RMS business, which included managing several consolidation and efficiency initiatives, along with global RMS technology enhancements.
In 2019, Ms. Dolph assumed the role of Corporate Vice President, Global Biologics. In this role, Ms. Dolph is responsible for leading the Company’s Biologics business, as well as managing the growth opportunities and expansion of the business. Most recently, she assumed responsibility for the Company’s Gene Therapy CDMO businesses, and in October 2021, was promoted to the position of Senior Vice President, Biologics Solutions.
Ms. Dolph holds a bachelor’s degree from the International Accountancy & Business School in Wuerzburg, Germany and was recognized by the Bavarian Government for outstanding performance.